Our Founder, Marty Keiser, and our CEO, Elizabeth Cormier-May, were guests on Matthew Zachary’s OffScrip Media podcast, Out of Patients.
Eric Kristiansen • 27 July 2021
Listen to Marty and Liz offer their thoughts and commercial insights into the diagnostics market! Approaching traditional hurdles with innovative solutions is the ONLY way to move the needle forward for our patients!
NEWPORT BEACH, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Mammogen, a female-led predictive health company developing RNA-powered molecular diagnostics for women’s health, today appointed Elise Berman, M.D., as Chief Medical Officer. Dr. Berman brings more than two decades of leadership across breast imaging, medical affairs, and clinical development. She joins Mammogen as the company advances genTRU-breast™ through clinical validation and toward commercialization.
Mammogen has announced the successful completion of a Series A financing round of up to $30 million, marking a significant milestone in the company's mission to transform breast cancer detection through innovative blood-based diagnostics.
Renowned global builder of boards and executive teams aligns with leading women's health innovator, signaling next phase of commercial growth